Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Socati was a U.S.-based cannabinoid ingredients and wellness products company focused on hemp genetics, cannabinoid science, extraction, purification, and large-scale manufacturing of THC-free and broad-spectrum hemp-derived ingredients. The company supplied precision cannabinoid ingredients such as cannabidiol, cannabigerol, and cannabinol, and also offered formulated finished products for consumer brands. Its capabilities emphasized food-grade and organic-certified production, analytical testing, and customizable cannabinoid profiles for wellness applications rather than prescription therapeutics. Socati was acquired by Yooma Wellness in March 2021 in a transaction valued at US$25 million. Public databases now generally describe Socati as closed or acquired, although some business directories still list legacy operations or locations under the brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Socati.